Grand Pearl Spa SkinCeuticals By Plastic Surgery Associates, Michigan, United States
Active Cosmetics

Two American market champions

The Division's expansion was remarkable in the United States, which has now become its 2nd largest country after France in terms of sales. The market was driven by SkinCeuticals and La Roche-Posay, which both continued to develop the dermocosmetics category in particular in drugstores(1).

SkinCeuticals, No.1 American medical aesthetic skincare brand worldwide(2)

In its home country, SkinCeuticals owes its success to a combination of three advantages: unique positioning, increased visibility and high value-added innovations. Its approach to skincare as an integral part of aesthetic procedures designed to improve their performance or lessen side effects. In 2016, studies demonstrated the post-procedure effectiveness of two facial skincare treatments: Metacell Renewal B3 (IPL) to complement intense pulsed light sessions, and Phyto Corrective Masque to calm the skin after laser treatment.
Phyto Corrective Masque and Metacell Renewal B3 by SkinCeuticals
+10.6% SkinCeuticals like-for-like sales growth in the United States

Visibility and scientific innovation

In 2016, SkinCeuticals opened some ten centres – premium spas or aesthetic clinics – where the brand works closely with aesthetic practitioners on an exclusive basis. It uses the centres to showcase its professional treatments at each stage of the consumer's treatment. Another success story in 2016: the innovative Triple Lipid Restore in the seniors market. This concentrated treatment contains three essential skin lipids in pure form: 2% ceramides, 4% natural cholesterol, and 2% fatty acids. Its launch was one of the most successful of the last eight years.
Triple Lipid Restore by SkinCeuticals
+15.3% La Roche-Posay like-for-like sales growth in the United States

La Roche-Posay winning over drugstores

La Roche-Posay – a trusted name in the fields of sun protection and acne-prone skin – ramped up its development in the United States. The brand was boosted by the Division’s creation of the dermocosmetics category in drugstores(1) such as CVS (750 openings in 2016) and Walgreens (870 sales outlet openings), where it has opened dedicated corners. Growth at La Roche-Posay was also driven by the impact of physicians’ recommendations, linked especially to the success of its Effaclar and Anthelios ranges.
Anthelios 60 and Effaclar range by La Roche-Posay
Share
Back
(1) Retailers offering products ranging from food items to pharmaceuticals.
(2) Source: Euromonitor International Limited, 2016.